Gerald Carlson

Chief Executive Officer at Phibro Animal Health (Belgium) SA

81 year

Process Industries

Health Technology

Government

Profile

Gerald K.
Carlson is currently the Chief Executive Officer at Phibro Animal Health (Belgium) SA. Previously, he worked as the Chief Operating Officer & Director at Phibro Animal Health Corp.
from 2014 to 2016.
He also worked as the Senior VP-Corporate Planning & Development at Ecolab, Inc. in 1998 and as the Commissioner-Trade & Development at State of Minnesota from 1999 to 2001.

Gerald Carlson active positions

Companies	Position	Start
Phibro Animal Health (Belgium) SA Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium	Chief Executive Officer	08/06/2011

All active positions of Gerald Carlson

Former positions of Gerald Carlson

Companies	Position	End
State of Minnesota	Corporate Officer/Principal	01/01/2001
ECOLAB INC.	Corporate Officer/Principal	01/10/1998
PHIBRO ANIMAL HEALTH CORPORATION	Chief Executive Officer	01/03/2014

See the detail of Gerald Carlson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gerald Carlson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
ECOLAB INC.	Process Industries
PHIBRO ANIMAL HEALTH CORPORATION	Health Technology

Private companies	2
State of Minnesota	Government
Phibro Animal Health (Belgium) SA Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium	Process Industries